Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.96
-0.17 (-2.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 329 | 325 | 672 | 547 | 715 | 611 | |
| Market Cap Growth | -0.10% | -51.64% | 22.71% | -23.44% | 17.04% | - | |
| Enterprise Value | 227 | 152 | 600 | 448 | 612 | 549 | |
| Last Close Price | 6.96 | 6.88 | 17.37 | 15.25 | 23.89 | 22.00 | |
| PS Ratio | 12.81 | 7.51 | 21.23 | 25.28 | 42.53 | 81.67 | |
| PB Ratio | 4.44 | 2.42 | 30.54 | 20.58 | 61.93 | 49.39 | |
| P/TBV Ratio | 5.21 | 2.61 | 57.66 | 33.06 | 580.25 | 487.96 | |
| P/FCF Ratio | - | - | - | - | 96.09 | - | |
| P/OCF Ratio | - | - | - | - | 77.58 | - | |
| EV/Sales Ratio | 8.78 | 3.52 | 18.97 | 20.67 | 36.40 | 73.34 | |
| EV/FCF Ratio | - | - | - | - | 82.24 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.04 | |
| Debt / FCF Ratio | - | - | - | - | 0.03 | - | |
| Asset Turnover | 0.14 | 0.27 | 0.25 | 0.18 | 0.14 | 0.08 | |
| Quick Ratio | 7.16 | 10.36 | 4.15 | 4.03 | 5.41 | 2.78 | |
| Current Ratio | 7.69 | 11.14 | 4.62 | 4.41 | 5.69 | 2.99 | |
| Return on Equity (ROE) | -64.30% | -58.08% | -223.22% | -273.06% | -448.22% | -217.21% | |
| Return on Assets (ROA) | -23.40% | -19.24% | -26.32% | -26.09% | -31.44% | -29.33% | |
| Return on Capital (ROIC) | -43.50% | -39.61% | -132.49% | -170.42% | -317.04% | -126.58% | |
| Return on Capital Employed (ROCE) | -54.10% | -26.70% | -54.00% | -49.70% | -56.50% | -51.30% | |
| Earnings Yield | -19.63% | -13.95% | -8.07% | -9.20% | -7.46% | -7.27% | |
| FCF Yield | -22.08% | -20.89% | -7.37% | -10.45% | 1.04% | -2.52% | |
| Buyback Yield / Dilution | -7.98% | -24.69% | -15.21% | -8.58% | -8.78% | -8.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.